Entheon Biomedical (XCNQ:ENBI) Receivables Turnover : 0.00 (As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Entheon Biomedical's Revenue for the three months ended in Feb. 2024 was C$0.00 Mil. Entheon Biomedical's average Accounts Receivable for the three months ended in Feb. 2024 was C$0.00 Mil.

Entheon Biomedical Receivables Turnover Historical Data

The historical data trend for Entheon Biomedical's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Receivables Turnover Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Receivables Turnover

Get a 7-Day Free Trial

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Entheon Biomedical's Receivables Turnover

For the Biotechnology subindustry, Entheon Biomedical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Receivables Turnover falls into.

Entheon Biomedical Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Entheon Biomedical's Receivables Turnover for the fiscal year that ended in Nov. 2023 is calculated as

	Receivables Turnover (A: Nov. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Nov. 2023 )	/ (	(Accounts Receivable (A: Nov. 2022 )	+	Accounts Receivable (A: Nov. 2023 ))	/	count )
=	0.25	/ (	(0	+	0)	/	1 )
=	0.25	/	0
=	N/A

Entheon Biomedical's Receivables Turnover for the quarter that ended in Feb. 2024 is calculated as

	Receivables Turnover (Q: Feb. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Feb. 2024 )	/ (	(Accounts Receivable (Q: Nov. 2023 )	+	Accounts Receivable (Q: Feb. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Entheon Biomedical (XCNQ:ENBI) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Entheon Biomedical Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines